Home
Forms Library
FDA eCTD Review Process

FDA eCTD Review Process 2025

FDA eCTD Review Process Preview on Page 1

Show details

4.1 out of 5

37 votes

The document outlines the FDA eCTD (electronic Common Technical Document) review process, highlighting workflow challenges, validation and review practices, and quality best practices. It discusses issues such as 'Refuse-to-File' letters, technical rejections, and complete response letters that can arise during the application review process. The document emphasizes the importance of error detection in submissions, common errors encountered, and best practices for ensuring compliance with FDA requirements.

Here's how it works

01. Edit your form online

Type text, add images, blackout confidential details, add comments, highlights and more.

02. Sign it in a few clicks

Draw your signature, type it, upload its image, or use your mobile device as a signature pad.

03. Share your form with others

Send it via email, link, or fax. You can also download it, export it or print it out.

The easiest way to edit FDA eCTD Review Process in PDF format online

Ease of Setup

DocHub User Ratings on G2

Ease of Use

DocHub User Ratings on G2

Handling documents with our comprehensive and user-friendly PDF editor is straightforward. Adhere to the instructions below to complete FDA eCTD Review Process online quickly and easily:

Log in to your account. Log in with your email and password or create a free account to try the service before upgrading the subscription.
Import a document. Drag and drop the file from your device or import it from other services, like Google Drive, OneDrive, Dropbox, or an external link.
Edit FDA eCTD Review Process. Quickly add and highlight text, insert images, checkmarks, and icons, drop new fillable fields, and rearrange or remove pages from your paperwork.
Get the FDA eCTD Review Process completed. Download your updated document, export it to the cloud, print it from the editor, or share it with other participants through a Shareable link or as an email attachment.

Make the most of DocHub, the most straightforward editor to quickly manage your paperwork online!

be ready to get more

Complete this form in 5 minutes or less

Get form

Got questions?

We have answers to the most popular questions from our customers. If you can't find an answer to your question, please contact us.

What is the FDA review process?

After completion of the first 3 phases of clinical trials, the Sponsor analyzes the data. If the data shows that the therapy is effective and safe, the company submits a New Drug Application (NDA) to the FDA.

What is the eCTD publishing process?

Step 1: Organize the documents ing to the eCTD structure (Modules 1-5). Step 2: Compile the documents using eCTD management software, which helps assemble the dossier in the required format. Step 3: Validate the submission dossier with eCTD validation tools to ensure compliance with technical requirements.

How long does the FDA standard review take?

Priority Review Designation In 1992, the FDA established a two-tiered system of review timesstandard review and priority review. A priority review designation means the FDAs goal is to make a decision within 6 months of receiving the application. This is 4 months earlier than the standard review time of 10 months.

What is the FDA standard review process?

Drugs are tested on people to make sure they are safe and effective. FDA review teams thoroughly examine all of the submitted data related to the drug or device and make a decision to approve or not to approve it. FDA monitors all drug and device safety once products are available for use by the public.

What is the FDA priority review Standard?

Priority Review means that FDA aims to take action on an application within six months, compared to 10 months under standard review. A Priority Review designation directs attention and resources to evaluate drugs that would significantly improve the treatment, diagnosis, or prevention of serious conditions.

What are the 4 phases of FDA approval?

Drug development can be divided into four phases: discovery, preclinical studies, clinical development and market approval. The image below provides an overview of the process, including an estimated timeline for each step. Lets go through the process step by step.

What is the timeline for FDA review?

Phase 1 studies (typically involve 20 to 80 people). Phase 2 studies (typically involve a few dozen to about 300 people). Phase 3 studies (typically involve several hundred to about 3,000 people). The pre-NDA period, just before a new drug application (NDA) is submitted.

FDA eCTD Review Process 2025

Here's how it works